Lucyoside B

Cat. No. M19150

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Lucyoside B inhibits the production of inflammatory mediators via both NF-κB and activator protein-1 pathways in activated macrophages.

Related NF-κB Products
DCZ5418 DCZ5418 is an inhibitor of TRIP13.
Ro 106-9920 Ro 106-9920 is a potent inhibitor of NF-kappaB.
MRS2693 trisodium MRS2693 trisodium is a selective P2Y6 agonist with an EC50 value of 0.015 μM.
PTD-p65-P1 Peptide TFA PTD-p65-P1 Peptide TFA is a potent, selective nuclear transcription factor NF-κB inhibitor and derives from the p65 subunit of NF-κB amino acid residues 271-282, which selectively inhibits NF-κB activation induced by various inflammatory stimulation, down-regulate NF-κB-mediated gene expression and up-regulate apoptosis.
Narlumosbart Narlumosbart is a human IgG4ҡ monoclonal antibody (mAb) that targets Receptor Activating Factor for Nuclear Factor κB Ligand (RANKL) and can be used in studies related to Giant Cell Tumor of Bone (GCTB).

Catalog